HCID 59558376, compound → HCID 59619667, compound

Participants

Reaction Steps

The title compound was synthesized in a similar manner as described for Example 1.1 using 8-bromo-1-(1,3-dimethyl-1H-pyrazol-4-yl)-3-methyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-one (Intermediate A) and 3-(2-methoxy-ethoxy)-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine (Stage 59.1.1) to give the title compound as a white solid. (HPLC: tR 2.17 min (Method A); M+H=445 MS-ES; 1H-NMR (d6-DMSO, 400 MHz) 8.99 (s, 1H), 8.35-8.27 (m, 2H), 8.18-8.08 (m, 2H), 8.04-7.97 (m, 1H), 7.61-7.56 (m, 1H), 7.44-7.38 (m, 1H), 4.25 (t, 2H), 3.89 (s, 3H), 3.71 (t, 2H), 3.57 (s, 3H), 3.31 (s, 3H), 1.96 (s, 3H))

Provenance & Evidence